Utz Q3 Sales Down 2.3%, Adjusted EBITDA Down 30.3% Ahead of $14.25 Take-Private
UTZ has more than doubled off its 52-week low of $6.78.
Summary
Utz reported a weak third quarter — sales down 2.3% and adjusted EBITDA down 30.3% — while confirming its $14.25-per-share take-private is on track, with all regulatory approvals in hand and a shareholder vote scheduled for November 13, 2026.
Key Events · Earnings and Guidance · UTZ
-
Q3 Sales Slip 2.3%
Net sales fell to $369.2 million from $377.8 million, with volume/mix down 5.2% partly offset by 2.9% higher pricing.
-
Profitability Collapses
Adjusted EBITDA fell 30.3% to $42.0 million and adjusted EPS dropped 56.5% to $0.10; net loss widened to $32.1 million from $20.2 million.
-
Cash Burn in the Quarter
Cash flow used in operations was $4.9 million and adjusted free cash flow was negative $15.5 million, versus positive $27.8 million a year earlier.
-
Take-Private on Track
The $14.25-per-share all-cash deal with Intersnack has satisfied all regulatory conditions; the special shareholder meeting is scheduled for November 13, 2026, with closing expected in Q4 2026.
Analysis · UTZ · Manufacturing
The third quarter deteriorated sharply: adjusted EBITDA fell 30.3% to $42.0 million and adjusted EPS dropped 56.5% to $0.10 as supply chain inflation and a weaker consumer squeezed margins. Normally these numbers would drive valuation, but they matter less now because the stock is being bought at a fixed $14.25 per share in cash by Intersnack. Still, they show the business is shrinking into the deal, and any renegotiation or financing wobble would land on a weaker operating base. All regulatory conditions are satisfied and the shareholder vote is set for November 13, 2026, so the outcome now rests on that vote and remaining closing conditions.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UTZ was trading at $14.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $6.78 to $14.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.